Picodya introduces game-changing technology with the proven potential to empower diagnostics access worldwide.
The company was founded in 2018 by Yehuda Yavets-Chen and Kibbutz Hatzerim, which established Netafim—the innovator of drip irrigation technology—five decades ago. While Netafim introduced “grow more with less,” Picodya’s pico technology will allow the world to “diagnose more with less.”
At Picodya, we continue and expand the innovative spirit and value of striving for a healthier planet.
Led by an exceptional team
25+ years of experience spanning business management, operations, R&D, and engineering. Tzvika was the CEO of ExtraPlastic, VP Operations and Director of Product Development at Netafim, and VP Service Supply chain at Orbotech. Currently serves as the Business Chairman of Kibbutz Hatzerim and a board member at Netafim.
A developer of complex multidisciplinary systems for over 30 years, Yehuda is the mastermind behind Picodya’s groundbreaking technology. He holds numerous patents and is the founder of several startups. These include Phinergy (Israel), Faro Innovation (Italy), and Advanced Robotics (USA).
Uri is a medical doctor and experienced health IT professional with a strong clinical, product, and business-management background.
Liraz is a Senior Biological Researcher, expert in immunoassay and genetic kits development in compliance with ISO and GMP standards.
Ilana is a life science technology specialist, inventor, and developer who has led product development with worldwide sales.
Tomer is a senior scientist with a 20-year track record in R&D management in the biomedical IVD industry.
Merav has more than 15 years of experience in regulatory and clinical affairs, mainly throughout development phases and successful submissions for FDA clearance and CE marking.
Ilina brings 12+ years in R&D with extensive Industrial experience in sensor product development & commercialization of IVD products for POC clinical diagnostics.
Lindy brings extensive experience in the biotech diagnostic industry developing and validating a variety of POC assays for IVD infectious diseases. Proficient in GLP bioanalytical and ADA immunoassay development including ELISA and MSD.
Yakov’s 14+ years in R&D includes technology & production, laboratory operations, and process development management.
10+ years in experimental design and execution, method development, data analysis, and DNA nanotechnology.
Eyal has vast experience in building data and analytics solutions using advanced statistical and machine learning models.
Over 2 decades of experience in technology and product development in cost-effective mass production of technologies.
Amir is a mechanical engineer who has been managing projects in multidisciplinary product development and engineering for 10+ years.
Gilad brings 30+ years of experience in the development and technical product management of multi-disciplinary systems over a wide spectrum of technologies.
Collaborating with world-class
30+ years in senior roles including CEO of Netafim Mexico, VP Americas, and VP Business Development for Netafim, and Business Chairman of Kibbutz Hatzerim. Currently Chairman of Negev Ecology, General Partner at SIBF, and board member at both Netafim and Kibbutz Hatzerim.
45+ years of experience in product development and engineering. Previously Netafim’s CTO, and VP Product, VP R&D, and Head of Research. BSc and MCs in electrical engineering and BSc in chemistry from the Technion and BSc in chemistry from BGU.
Current managing director at SIBF VC with 15+ years of VC experience managing and mentoring startups; chairman and BoD member for several fast-growing tech companies.
Acting chairman of Institutional Review Board at Sheba. Former Director of Clinical Microbiology at Sheba Medical Center; Former Chairman of the Israeli Society for Infectious Disease.
Prof. of immunology at the Weizmann Institute with 50+ years in research. Prof. Cohen has been the Director of T Cell Vaccination, Director of Robert Koch-Minerva Center, Director of National Institute of Biotechnology, among others. Recipient of numerous awards including the Robert Koch Prize (Germany), the Teva Founders Prize, the AESKU Prize, and an UFIS Prize.
Associate Professor at the Faculty of Life Sciences, Bar-Ilan University, with 15+ years of experience in proteomics mapping viral interactions against the human proteome. PhD in biological chemistry from the Weizmann Institute.
Chief, Human Immunology Section at NIH Vaccine Research Center; Director, PREMISE pandemic preparedness program. 20+ years of experience at the VRC/NIH with 15+ years as a tenured senior investigator. Recognized global KOL in immunology.
Medical Director of Raphael Hospital and founding Director of Men’s Health. Expert in urologic oncology with extensive research and clinical expertise in cancer screening and early detection techniques.
Senior Researcher at the Israel Institute for Biological Research and an expert in the development of immunological assays for evaluation of cellular and humoral immune responses. Ph.D. from Weizmann Institute and a Clinical Research Curriculum Certificate from the NIH.
38 years of senior management experience in R&D, process development, and manufacturing of point-of-care in vitro diagnostics. Former managing director of Orgenics, Alere’s Israel division, acquired by Abbott in 2016 . Senior Director of Global Scientific Support, Abbott Rapid Diagnostics, 2016 - 2019. PhD. in Biochemistry from the Albert Einstein College of Medicine and a Rockefeller Foundation Post-Doctoral fellowship at Harvard Medical School.
Join our team
Join us as we pave the way to a healthier planet. See the open positions and feel free to apply.
The development of control and automation applications for the company’s products, testing jigs and production tools.